Skip to main content
OpenTrials
Completed

NCT Number: NCT02555956

Grid Laser for Diffuse Diabetic Maculopathy

Diabetic related complications are increasing day by day due to increse in the number of diabetic patients all over the world. Diabetic macular edema is one of them and a major cause of vision imparment. Various kind of treatment modalities are preent to treat this coplication. Grid laser is one treatment modality. Laser phtocoagulation is a destrictive procedure.Laser power if kept to aminimum can get the desired results without severe destruction to the retina . In this study, the investigators are going to document the effect of minimal grid laser tn loss o overcome the visioe to diabetic macular edema.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetic Macular Edema

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dow universty Hospital,Dow international Medical college

Karachi, Sindh, 75500, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diabetic patients with macular edema.
  • both sexes
  • conset to participate.

Exclusion criteria

  • focal edema.
  • patients requiring only the focal laser.
  • patients with proferative diabetic retinopathy.
  • Patients with ischaemic maculopathy on fundus fluorescein angiography.

Treatment and study plan

Primary outcomes

  1. Improvement of visual acuity after grid laser

    Time frame: 6 week

    Visual acuity will be mesured pre laser and 06 weeks post laser

Secondary outcomes

  1. Complication

    Time frame: during first six weeks after laser

    Patiens willbe asked and examined for any potentiail anticipated complication.

Sponsors and collaborators

Lead sponsor

Dow University of Health Sciences

Other

Registry information

Official study title

Subthreshold Double Frequency Nd. YAG Grid Laser for Diffuse Diabetic Maculopathy

Acronym: MMG

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Sep 22, 2015
Registry last updated
Sep 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.